Locations:
Search
Characterizing genetic architecture of clinical subtypes may accelerate targeted therapy
The relationship between MTHFR variants and thrombosis risk is a complex issue, but current evidence points to no association between the most common variants and an elevated risk
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
A conversation with Feixiong Cheng, PhD, about his wide-ranging research initiatives
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Authors discuss ethical challenges associated with sponsored genetic testing
Discovery Accelerator Partnership with IBM Deploys Advanced Computing Technologies to Supercharge Healthcare Research
Cleveland Clinic researchers receive $2 million grant from the National Institutes of Health
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Advertisement
Advertisement